IMNN earnings: real EPS beat/miss history, analyst consensus Buy, P/E -0.27. Updated 2026-07-23.
Imunon (IMNN) Research Hub
Imunon (IMNN) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 1.47 USD (-2.65%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.27, market cap 0.00B. This hub links to the full technical, earnings and options research available for IMNN.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.47 USD (-2.65%) |
| 52-week range | 1.42 USD – 2.18 USD |
| Trend regime | Range |
| 14-day RSI | 31.6 (Bearish) |
| Trailing P/E | -0.27 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for IMNN
Covered Call on IMNN: how it works, illustrative setup around the real 1.47 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IMNN: how it works, illustrative setup around the real 1.47 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IMNN: how it works, illustrative setup around the real 1.47 USD price, max profit/loss, breakeven and when to use it. Educational.
IMNN technical analysis: range, last 1.47 USD, RSI 31.6, 52w range 1.42 USD–2.18 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is IMNN in?
Imunon (IMNN) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is IMNN in an uptrend or downtrend?
As of 2026-09-11, IMNN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IMNN's trailing P/E ratio?
IMNN's trailing P/E is -0.27, with a market cap of 0.00B. See the earnings research page for full valuation detail.